Firefly Neuroscience (AIFF) Asset Utilization Ratio (2011 - 2026)
Firefly Neuroscience (AIFF) posted Asset Utilization Ratio of 0.13 for Q2 2026, down 12.24% on a QoQ basis from 0.15 in Q1 2026, and up 323.51% year-over-year from 0.03 in Q2 2025.
Analysis
Firefly Neuroscience (AIFF) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Firefly Neuroscience has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.13 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 323.51% year-over-year to 0.13 in Q2 2026; TTM through Jun 2026 was 0.13, a 323.51% increase from a year earlier, with the FY2025 full-year figure at 0.15, up 595.12% from the prior year.
- Asset Utilization Ratio was 0.13 for Q2 2026 at Firefly Neuroscience, down from 0.15 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.33 in Q1 2023, with the low at 0.02 in Q1 2025.
- Average Asset Utilization Ratio over 5 years is 0.51, with a median of 0.63 recorded in 2022.
- The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio sank 98.28% in 2024, then surged 851.83% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.9 in 2022, then grew by 19.31% to 1.07 in 2023, then tumbled by 97.66% to 0.03 in 2024, then soared by 298.35% to 0.1 in 2025, then soared by 30.25% to 0.13 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.13 (Q2 2026), 0.15 (Q1 2026), and 0.1 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 0.57 |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 0.65 |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 0.58 |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 0.26 |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 0.39 |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 0.59 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 0.79 |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 0.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.13 |
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.02 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.65 |
| Dec 31, 2023 | 1.07 |
| Sep 30, 2023 | 1.07 |
| Jun 30, 2023 | 1.25 |
| Mar 31, 2023 | 1.33 |
| Dec 31, 2022 | 0.90 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.65 |
| Mar 31, 2022 | 0.65 |
| Dec 31, 2021 | 0.91 |
| Sep 30, 2021 | 1.91 |
| Jun 30, 2021 | 2.62 |